Researchers from the University of Copenhagen have succeeded in targeting and killing a single bacterial species (E. coli) without causing harm to the surrounding community of commensal bacteria in a simulated small intestinal microbiome using a cocktail of viruses (bacteriophages). The study proved that this approach is as effective in killing the targeted E. coli as broad-spectrum antibiotics but has much gentler impact on the normal, and often beneficial, microflora compared to antibiotics.
The experiment underlines the potential of using bacteriophages for target-specific manipulation of complex microbial communities and potentially replacing or supplementing usage of antibiotics as therapeutic agent against bacterial diseases.
Imagine that you have become ill because you have eaten some food that contained pathogenic bacteria. You keep running to the toilet and you may also throw up. You go to the doctor and are prescribed broad-spectrum antibiotics, which – in addition to killing the bad bacteria in your intestinal flora – carpet bomb the complex community of commensal bacteria forming a healthy intestinal flora.
New research from the Department of Food Science (FOOD) at the University of Copenhagen suggests that, in the not-too-distant future, it might be possible to drink a cocktail of selective viruses (bacteriophages) that travel directly into the gut and kill the disease-causing bacteria, so you get better – without the use of antibiotics and without harming the beneficial commensal intestinal bacteria.
The researchers have come a step closer to this scenario.
“The research shows that we have an opportunity to kill specific bacteria without collateral damage to the other, and otherwise healthy, intestinal flora”, says Professor Dennis Sandris Nielsen from Department of Food Science at the University of Copenhagen.
He emphasizes that the result was created in a model of the small intestine; so the next step will be to test the study on mice and later on humans if such treatment is to be implemented.
Model of the small intestine
The model in which the research has been conducted, TSI, was developed at FOOD by postdoc Tomasz Cieplak, in connection with his PhD project, with Professor Dennis Sandris Nielsen as his supervisor.
“The novelty of the TSI model is that it simulates the presence of the small intestinal microbiota, which has largely been overlooked in other models of the small intestine. Other models existing on the market simulate only the purely biophysical processes, such as bile salts and digestive enzymes or pH, but here we included this important aspect of human gut physiology to mimic the small intestine more closely”, says Cieplak.
The composition of the intestinal flora in the model is representative of how the intestinal flora could look in a healthy person. In the study, researchers have added E. coli bacteria to the intestinal flora, which they then attempted to kill by utilizing a targeted cocktail of viruses (bacteriophages) developed by the company Intralytix.
New research in an old method
“Using bacteriophages to kill pathogenic bacteria is not new and has actually been used to treat food-borne illnesses and other diseases in Eastern Europe for almost a century, but it was not until relatively recently that this approach started to attract more widespread research interest”, says Dennis Sandris Nielsen
The research into combating infectious diseases with viruses was not as interesting because you already had an effective treatment with antibiotics.
“It is different today, where resistance to antibiotics is an increasing problem in modern medicine. At the same time, we have become more aware of how important the commensal bacteria in the gut are for our health”, says Nielsen.
Phages (bacteriophages) are viruses that attack bacteria – in this context, bacteria in our intestinal microbiome. The classic lytic phage attacks bacteria by attaching to the surface of the bacterium and injecting its genetic material into the bacterium. It takes over the bacterium’s metabolism and redirects it to create new viruses. The bacterial cell, now taken over by the phage, will explode and send a lot of new phages into the surrounding area, which can then attack new bacteria.
Postdoc at FOOD Tomasz Cieplak about the research and the TSI:
The Latest on: Bacteriophages
via Google News
The Latest on: Bacteriophages
- Global Botanical and Plant-Derived Drugs Market | Post Pandemic Impact Analysis | Technavioon December 4, 2020 at 10:46 am
The botanical and plant-derived drugs market is poised to grow by USD 13.67 billion during 2020-2024, progressing at a CAGR of over 7% during the forecast period. This ...
- Now is the Time to Get Smart on HSAson December 4, 2020 at 9:00 am
Looking for solutions to help plan for medical costs today and in the future? Health Savings Accounts are a powerful tool that can help you take control of your health and financial wellness needs.
- Amazon Launches Amazon Pharmacy to Sell Prescription Drugs Nationwideon December 4, 2020 at 8:13 am
Amazon.com announced a new online store, Amazon Pharmacy, which will sell and deliver prescription drugs nationwide.
- Prioritizing Education Is a Smart Political Strategyon December 4, 2020 at 7:45 am
Joe Biden should announce education as his first major policy initiative, even as he continues to battle the pandemic.
- DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summiton December 3, 2020 at 5:35 pm
DermTech, Inc. (NASDAQ:DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the presentation of a ...
- Global Artificial Intelligence (AI) in Drug Discovery Market Analysis with Key Players, Applications, Trends and Forecasts to 2026on December 3, 2020 at 1:13 pm
The analyst has predicted the Global Artificial Intelligence (AI) in Drug Discovery Market is valued approximately at USD 260 million in 2019 and is anticipated to grow with a healthy growth rate of ...
- The dark side of ‘smart drugs’ and mind-enhancerson December 3, 2020 at 2:25 am
Twenty-seven year old Danish Alam* is no longer afraid of academic exams. He now has a “smart substance” to help him. He does not forget things and stays focused while studying like never before. But ...
- Longs Drugs Debuts HealthHUB Experience to Serve Hawaiion December 2, 2020 at 10:00 am
Longs Drugs and its parent company CVS Health (NYSE: CVS) today held a community grand opening ceremony and blessing to debut HealthHUB, a ...
- SMART researchers develop customised targeting of bacteria using lysinson December 1, 2020 at 8:14 am
Researchers from SMART have developed a method to produce engineered lysins that can be used to selectively kill bacteria of interest while leaving others unharmed. The discovery presents a promising ...
via Bing News